Precisely Strengthens its Location Intelligence Offering Through the Acquisition of Transerve
31.1.2023 16:00:00 EET | Business Wire | Press release
Precisely, the global leader in data integrity, today announced it has acquired Transerve, a location intelligence and data provider with expertise in spatial data handling, processing and analysis.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230131005192/en/
Precisely, the global leader in data integrity, announces its acquisition of Transerve, a location intelligence and data provider with expertise in spatial data handling, processing and analysis. (Graphic: Business Wire)
Transerve, headquartered in the Goa region of India, provides a cloud-native location intelligence solution and data library with curated datasets, enabling fast time to value with a nimble spatial analytics SaaS solution for enterprise and midsize companies. Transerve incorporates a simple, yet powerful, combination of geospatial artificial intelligence (AI), machine learning (ML) and geoprocessing that supports data democratization by making location analysis and data enrichment available to data-centric employees without requiring the need for geographic information system (GIS) expertise.
Customers in industries such as banking, insurance, telco, government, retail, and real estate will benefit from a more complete and contextual picture of data that informs decision-making including, but not limited to, market potential, risk assessment, site selection and optimization, and more. Transerve allows users to enrich data with high-quality, curated spatial datasets and easily create and share web-based maps.
“In the past, deriving insights from location and creating visualizations was the domain of GIS specialists,” said Clarence Hempfield, Senior Vice President of Product Management, Location Intelligence at Precisely. “With the acquisition of Transerve, Precisely adds new SaaS location intelligence capabilities to its portfolio of data integrity software and data. This allows users, without specialized knowledge or skills, to leverage location data and analytics and derive new insights about their business.”
“We've been on a mission to make spatial data easier to access, understand and take action on for businesses," said Ashwanii Rawat, CEO and Co-Founder at Transerve. "We're delighted to be joining Precisely who shares this passion for location intelligence and bringing the power of location data to everyday data roles to make an impact for the companies we serve and broaden our impact in the market.”
This acquisition follows the launch of the Precisely Data Integrity Suite, an integrated, interoperable suite designed to deliver accurate, consistent, contextualized data to businesses. Learn more about the Data Integrity Suite.
About Precisely
Precisely is the global leader in data integrity, providing accuracy, consistency, and context in data for 12,000 customers in more than 100 countries, including 99 of the Fortune 100. Precisely’s data integration, data quality, data governance, location intelligence, and data enrichment products power better business decisions to create better outcomes. Learn more at www.precisely.com.
About Transerve
Founded in 2009, Transerve is a location intelligence company based in Panaji, India that uses geospatial technology to enable digital transformation and effective decision-making. It helps in deploying customized applications for asset tracking and mapping, monitoring of projects, spatial data collection with geo-tagged pictures and videos, and to share maps with key stakeholders or the public. Learn more at www.transerve.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230131005192/en/
Contact information
Press
Emma Forrest
press@precisely.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 12:47:00 EEST | Press release
Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food products. Within this inspiring premise, Good Food Makers confirms itself as one of the main levers f
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 11:16:00 EEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 09:00:00 EEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin ® Epiduo ® Acne Gel Prescription-to-OTC Switch22.5.2026 19:25:00 EEST | Press release
Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) use in ages 12 years and older, marking a significant Prescription-to-OTC transition in acne care. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260522074280/en/ The U.S. FDA approves Differin® Epiduo® Acne Gel Prescription-to-OTC switch This milestone represents yet another example of Galderma’s unique Integrated Dermatology strategy, demonstrating how proven innovations from its Therapeutic Dermatology portfolio can further strengthen its Dermatological Skincare offerings. The Prescription‑to‑OTC transition highlights Galderma’s scale and expertise in successfully commercializing dermatology innovations across the full spectrum of acne care. With the appro
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom